Inflammatory bowel disease (IBD) is a chronic ailment of the digestive system. People who have it have pain in the abdominal region, bloating, and blood in the stool. The goal of medical treatment is to stop the abnormal inflammation and maintain remission. Inflammatory bowel disease is not contagious, although it can cause serious health issues.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4634
Increasing prevalence of Crohn’s disease and ulcerative colitis is expected to propel the global inflammatory bowel disease market growth over the forecast period. As per the Centers for Disease Control and Prevention (CDC), in 2015, inflammatory bowel disease, which is either Crohn’s disease or ulcerative colitis, was reported among 1.3% of the U.S. adults that is around 3 million people. As a result of this, the demand for adequate treatment options such as medication, surgical operation, and medical procedures such as enema has increased.
However, high capital investment for drug discovery and stringent regulations on drug approvals are expected to hinder the global inflammatory bowel disease market growth over the forecast period.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4634
Impact of COVID-19
The outbreak of the COVID-19 pandemic significantly affected growth of the global inflammatory bowel disease market. Since many countries adopted stringent nationwide lockdown policies to curb the virus, manufacturing activities across different sectors were temporarily suspended. Besides, massive disruption in the global supply chain industry led to a slowdown in economic activities across the world. However, declining cases of novel coronavirus and rollout of vaccines are expected to support the market is regaining its lost traction.
The global inflammatory bowel disease market is expected to expand, exhibiting a CAGR of 4.9% over the forecast period. This is owing to increasing adoption of biologics and biosimilar for the treatment of the said disease. For instance, in October 2021, Boehringer Ingelheim received the U.S. Food and Drug Administration (FDA) approval for Cyltezo the first interchange biosimilar product to treat inflammatory diseases such as Crohn’s disease.
Among regions, North America is expected to witness significant growth in the global inflammatory bowel disease market during the forecast period. This is owing to increasing adoption of novel drugs, and the presence of well-established healthcare infrastructure in the region.
Key companies involved in the global inflammatory bowel disease market are AbbVie Inc., Pfizer Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, and Takeda Pharmaceutical Company Limited
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4634
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Inflammatory Bowel Disease Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Inflammatory Bowel Disease Industry Impact
Chapter 2 Global Inflammatory Bowel Disease Competition by Types, Applications, and Top Regions and Countries
2.1 Global Inflammatory Bowel Disease (Volume and Value) by Type
2.3 Global Inflammatory Bowel Disease (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Inflammatory Bowel Disease Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Inflammatory Bowel Disease Market Analysis
Chapter 6 East Asia Inflammatory Bowel Disease Market Analysis
Chapter 7 Europe Inflammatory Bowel Disease Market Analysis
Chapter 8 South Asia Inflammatory Bowel Disease Market Analysis
Chapter 9 Southeast Asia Inflammatory Bowel Disease Market Analysis
Chapter 10 Middle East Inflammatory Bowel Disease Market Analysis
Chapter 11 Africa Inflammatory Bowel Disease Market Analysis
Chapter 12 Oceania Inflammatory Bowel Disease Market Analysis
Chapter 13 South America Inflammatory Bowel Disease Market Analysis
Chapter 14 Company Profiles and Key Figures in Inflammatory Bowel Disease Business
Chapter 15 Global Inflammatory Bowel Disease Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027